ORIGINAL ARTICLES. Revisiting Autonomic Dysfunction in End-Stage Renal Disease Patients
|
|
- Stella Wright
- 6 years ago
- Views:
Transcription
1 ORIGINAL ARTICLES Revisiting Autonomic Dysfunction in End-Stage Renal Disease Patients Jocemir R. Lugon 1, Elias A. Warrak 1, Adriano S. Lugon 1, Bruno A. Salvador 2, Antonio C. L. Nobrega 2 1 Department of Clinical Medicine and 2 Department of Physiology, Universidade Federal Fluminense, Niterói-RJ, Brazil. Background: Autonomic dysfunction is frequent in endstage renal disease (ESRD) patients, but both the relative involvement of the parasympathetic and sympathetic branches and the role of antihypertensive drugs in this setting are still controversial. The present study addressed these issues employing a battery of standard noninvasive cardiovascular autonomic tests. Methods: Sympathetic (S) function was evaluated by responses of both systolic blood pressure (BP) to passive tilting and diastolic BP to handgrip; parasympathetic (P) function, through the respiratory sinus arrhythmia test and the heart rate response to the 4-s unloaded exercise test. Additional tests influenced by both branches of the autonomic system (P þ S) were accomplished by the assessment of heart rate response to the Valsalva maneuver, handgrip, and tilting. Results: Studied subjects belonged to one of the three groups: not requiring BP medications (n ¼ 11; 8 men, 3 women); receiving antihypertensive therapy (n ¼ 36; 21 men, 15 women); and apparently healthy controls (n ¼ 15; 10 men, 5 women). When the variables grouped according to the branch of the autonomic nervous system predominantly probed were analyzed, only the frequency of impaired sympathetic autonomic responses was higher in compared to controls (55 vs. 23%, P ¼ 0.040). In contrast, when receiving were compared to controls, the differences became significant in S, P, and P þ S tests (46 vs. 23%, P ¼ 0.045; 22 vs. 3%, Correspondence to: Jocemir R. Lugon, R. Haddock Lobo 369/309, Tijuca Rio de Janeiro-RJ, Brazil. jocerl@hospital.huap.uff.br This study was presented at ASN/ISN World Congress of Nephrology, San Francisco, California, USA, October P ¼ 0.020; and 34 vs. 13%, P ¼ 0.010, respectively). With the criterion of more than one positive finding in any of the variables examined for diagnosing autonomic dysfunction, the prevalence of autonomic dysfunction was 20% in controls, 64% in (P ¼ vs. controls), and 67% in receiving (P ¼ vs. controls). Conclusions: ESRD continues to be associated with a high prevalence of autonomic dysfunction. receiving were found to have detectable impairment in the entire autonomic system in contrast to those in whom inadequate responses were restricted to the sympathetic branch. Hemodial Int. 2003; 7(3): Key words Hemodialysis, end-stage renal disease, autonomic dysfunction, blood pressure drugs Introduction Autonomic dysfunction is known to be common in endstage renal disease (ESRD) patients [1 3] and may contribute to dialysis-related hypotensive episodes [4,5]. Moreover, autonomic dysfunction has also been associated with other fatal and nonfatal cardiovascularevents[6,7]. In the past decades the treatment offered to ESRD patients undergoing maintenance hemodialysis has improved substantially. Anemia is now better controlled [8]. Side effects of the new-generation blood pressure (BP) drugs are less prominent. Modern machinery is provided with devices that yield precise ultrafiltration control. Available membranes are more biocompatible and efficient with higher permeability to both water and solutes [9]. These changes were accompanied by a focus on the dialysis prescription and adequacy of dialysis dose, resulting in an increase of survival and better 198
2 Hemodialysis International, Vol. 7, No. 3, 2003 quality of life [10]. Whether these advances have influenced the prevalence of autonomic dysfunction is uncertain, and the relative importance of parasympathetic and sympathetic branches and the role of antihypertensive drugs in autonomic dysfunction in dialysis patients are still controversial. Sympathetic and parasympathetic systems play complementary roles in the regulation of the cardiovascular system. The extent of influence of ESRD on each branch of the system may not be equivalent and may result in different patterns of autonomic dysfunction. Moreover, antihypertensive drugs may reflexively inhibit or activate the sympathetic and/or the parasympathetic systems modifying the autonomic regulation. Accordingly, the present study was designed to address these issues employing standard noninvasive cardiovascular autonomic tests. Methods Patients with ESRD were recruited from three dialysis centers in Rio de Janeiro, Brazil. Informed consent was obtained and the protocol approved by the ethical committee of the Medical School. Chronic medications, including those for blood pressure control, were continued during the study. All who were determined by the investigators to be capable of performing the battery of tests who did not have any of the exclusion criteria were enrolled. To qualify, patients had to be receiving dialysis for at least 6 months and had to be 18 to 70 years old. Patients with diabetes mellitus, Hansen s disease, and amyloidosis or presenting for examination with systolic BP 190 mm Hg and/or diastolic BP 120 mm Hg were excluded. Patients were treated using dialysis machines equipped with a programmable ultrafiltration control device (Model 2008S or 4008B, Fresenius Medical Care AG, Bad Homburg, Germany). The dialysis program consisted of three sessions of 3.5- to 4.5-hr duration per week, blood flow of ml/min, bicarbonatebuffered dialysate ([Ca 2þ ], 3.5 meq/l) at 500 ml/min, and low-flow hollow-fiber dialyzers. Reverse osmosis was used to provide water treatment. The autonomic tests were carried out on a nondialysis day. A paired control group of healthy volunteers recruited among medical doctors, students, and laboratory personnel was also examined. Subjects were instructed to refrain from smoking and drinking coffee for at least 2 hr before the tests. Once in the laboratory they received a full explanation about the procedures and purpose of the study and underwent a clinical examination that included resting blood pressure determination. They were allowed to practice the techniques of the tests for 10 min and to rest thereafter for 15 min. An additional rest period of 5 min in the supine position was requested before beginning the tests. During evaluations, heart rate was Lugon et al. continuously monitored by telemetry (Polar Vantage, Electric Oy, Finland) and the BP was measured with a calibrated aneroid sphygmomanometer. Sympathetic evaluation Passive tilting and change in systolic BP (reference value [RV] 10 mm Hg). After 5 min in the supine position, the subjects were passively tilted over 20 s to 70 using a manual-driven table. The systolic BP was measured every 30 s for 5 min. Static handgrip and change in diastolic BP (RV 3 25 mm Hg). In the sitting position, the maximal voluntary contraction (MVC) of the dominant hand was determined as the peak force achieved in three attempts. The subjects were then asked to sustain 30% of MVC as long as possible. The diastolic BP was measured every 30 s throughout the sustained contraction. Parasympathetic evaluation Respiratory sinus arrhythmia (RV 1.1). The subject was oriented to perform two controlled 12-s-long respiratory cycles (6 s for inspiration and expiration) with maximal changes in pulmonary volumes (from residual volume to total lung capacity). The heart rate response was measured by the ratio between the longest R-R interval during expiration and the shortest one during inspiration. Four-second exercise test [11] (RV 1.1). The subject executed a fast unloaded cycling on a cycle ergometer for 4 s, from the fourth to the eighth second, of a 12-s maximal inspiratory apnea. The heart rate response to exercise was measured by the ratio between the last R-R interval immediately before the onset of exercise and the shortest R-R interval during exertion. Combined sympathetic and parasympathetic evaluation Valsalva maneuver (RV 1.20). While seated, subjects were instructed to blow against a closed circuit connected to an aneroid manometer to generate 40 mm Hg for 15 s. The heart rate response was determined by the ratio (Valsalva index) between the longest R-R interval after the maneuver and the shortest one during the expiratory strain. Static handgrip and heart rate response (RV 3 10 bpm). Static handgrip (performed as above) and heart rate response were measured by the difference between the peak value during sustained contraction and the one obtained at rest. Passive tilting and heart rate response (RV 1.1). Passive tilting (performed as above) and heart rate response were assessed by the ratio between the longest R-R interval around the 30th second and the shortest R-R interval around the 15th second starting from the moment the upright position was reached. For statistical analysis the unpaired t test was used to compare independent numeric data and Fisher s Exact 199
3 Autonomic Dysfunction in ESRD Hemodialysis International, Vol. 7, No. 3, 2003 TABLE I test was used to compare discrete variables. Significance was set at the level of P < Results General features of patients and controls. receiving N Gender (M/F) 10/5 8/3 21/15 Age (years) a Race (B/W) 7/8 8/3 25/11 Time on dialysis (months) n.a Primary renal disease Nephrosclerosis n.a Chronic n.a. 1 9 glomerulonephritis Lupus nephropathy n.a. 1 1 APKD n.a. 1 2 Other n.a. 1 5 Unknown n.a. 2 3 a Mean SD. n.a. ¼ not applicable. The first 52 who agreed to participate in the study were enrolled. Complete data were obtained in 47. Fifteen of 17 initially recruited controls accomplished the autonomic test battery. The general features of the patients and controls are presented in Table I. Eleven did not receive BP medications. Groups did not differ in age and distribution of either gender or race. had been receiving dialysis for and months, respectively (with and without, n.s.). Of those patients receiving treatment for hypertension, 21 were receiving one BP drug, 7 receiving two drugs, 6 receiving three drugs, and 1 receiving four drugs. Drug families were as follows: ACE inhibitor 20, a2-agonist 15, b-blocker 10, calcium channel blocker 6, vasodilator 5, AT-1 antagonist 1, and diuretic 1. Findings regarding the variables that predominantly evaluate the sympathetic branch of the autonomic nervous system are presented in Table II. Inadequate systolic BP responses to passive tilting were seen in 13% of controls, 36% of, and 39% of receiving. Similar inadequate responses of the diastolic BP in the handgrip test occurred in 31, 73, and 53% of controls and the two patient groups, respectively. When data from the two sympathetic tests were pooled, the frequencies of inadequate response in both groups of were found to be statistically higher than in controls (55 vs. 23%, P ¼ 0.040, relative risk [RR] 2.08; 95% CI for ESRD patients ; and 46 vs. 23%, P ¼ 0.045, RR 1.31, 95% CI for receiving ). Data pertaining to the predominant evaluation of the parasympathetic branch of the autonomic nervous system are summarized in Table III. On the respiratory sinus arrhythmia test, values were in the accepted normal range in all of the controls, 82% of not receiving, and 83% of the receiving. When considering the 4-s unloaded exercise test, responses in the normal range were seen in 94, 91, and 72% of subjects, respectively. Again, a statistically significant difference was observed when the two parasympathetic tests were analyzed altogether. Here, the frequency of abnormal responses was higher in ESRD patients receiving when compared to controls (22 vs. 3%, P ¼ 0.020, RR 1.43, 95% CI ). Results of the three variables influenced by both sympathetic and parasympathetic branches of the autonomic nervous system are presented in Table IV. The tilting index was abnormal in none of the controls, 18% of, and 8% of receiving ; the Valsalva index in 6, 9, and 39%, respectively; and the variation of heart rate on handgrip test in 31, 36, and 56%, respectively. The frequency of impaired responses in the Valsalva test was significantly higher in receiving BP drugs compared to both controls (P ¼ 0.003, RR 2.02, 95% CI ) and BP drugs (P ¼ 0.013, RR 1.71, 95% CI ). When TABLE II Frequency (f ) of abnormalities on tests that predominantly evaluate the sympathetic autonomic system a. TABLE III Frequency (f) of abnormalities on tests that predominantly evaluate the parasympathetic autonomic system a. receiving ESRD receiving Change in systolic BP on 2 (13) 4 (36) 14 (39) passive tilting (>10 mm Hg) Change in diastolic BP on 5 (31) 8 (73) 19 (53) handgrip (<25 mm Hg) All 7 (23) 12 (55) b 33 (46) b a Data are presented as f(%). b P < 0.05 vs. controls. Respiratory sinus (0) 2 (18) 6 (17) arrhythmia (<1.10) 4-s unloaded exercise 1 (6) 1 (9) 10 (28) test (<1.10) All 1 (3) 3 (14) 16 (22) b a Data are presented as f(%). b P < 0.05 vs. controls. 200
4 Hemodialysis International, Vol. 7, No. 3, 2003 TABLE IV Frequency (f) of abnormalities on tests that evaluate both the sympathetic and the parasympathetic autonomic system a. receiving Tilting index (<1.10) (0) 2 (18) 3 (8) Valsalva index (<1.20) 1 (6) 1 (9) 14 (39) b Variation of heart rate 5 (31) 4 (36) 20 (56) on handgrip (<10) All 6 (13) 7 (21) 37 (34) c a Data are presented as f(%). b P< 0.05 vs. controls and ESRD. c P< 0.05 vs. controls. these tests were analyzed as a group, the frequency of inadequate responses in BP drugs was significantly different from controls (34 vs. 13%, P ¼ 0.010, RR 1.33, 95% CI ). In view of the number of positive findings in the control group, additional analyses were performed in an attempt to discern a combination that would be the most discriminative between and controls (Table V). The finding of more than one positive test in any of the variables examined for diagnosis of autonomic dysfunction was found to be the best predictor of autonomic dysfunction. Using this criterion, controls had impaired autonomic function in 20% of cases, ESRD patients in 64% of cases (P ¼ vs. controls, RR 1.78, 95% CI ), and receiving in 67% of cases (P ¼ vs. controls, RR 2.80, 95% CI ). When both ESRD groups were analyzed together, impaired responses were seen in 66% (P ¼ vs. controls, RR 1.60, 95% CI ). Discussion Autonomic dysfunction has been known to be a frequent abnormality in [1 4] but its role in the high cardiovascular mortality of is still a matter of controversy [12,13]. Some authors have reported a high incidence of cardiac arrhythmias in hemodialysis patients with associated autonomic dysfunction in standard tests, including paroxysmal atrial TABLE V Frequency (f) of cases with one or fewer and more than one altered autonomic test. Inadequate responses not receiving receiving 1 12 (80) 4 (36) 12 (33) >1 3 (20) 7 (64) b 24 (67) b a Data are presented as f (%). b P < 0.05 vs. controls. Lugon et al. fibrillation, ventricular ectopy, and ventricular tachycardia [6]. The importance of baroreceptor sensitivity impairment has been emphasized in the increased risk of death following myocardial infarction [14]. Finally, the prolongation of QT interval found in patients with impaired heart rate response to respiration and the Valsalva maneuver has been associated with sudden cardiac death [15]. In a study of 104 diabetic and 184 nondiabetic patients awaiting renal or combined renal pancreatic transplantation and with the use of power spectral analysis techniques to detect autonomic dysfunction, it was demonstrated that only one of the five deceased patients displayed normal values for all eight autonomic function measurements employed [7]. The present study was prospectively designed to assess the prevalence of sympathetic and parasympathetic dysfunction in receiving current standard hemodialysis treatment and the role of BP drugs in the autonomic dysfunction found. Changes in systolic BP in passive tilting and in diastolic BP in static handgrip were used as the sympathetic tests; respiratory sinus arrhythmia and the 4-s exercise test were used as the parasympathetic tests; and finally the Valsalva index and the heart rate responses to both static handgrip and tilting were used as the tests that probed both branches of the autonomous nervous system. Overall, defective sympathetic responses were found more frequently than parasympathetic ones in either or controls, suggesting that they were more sensitive but less specific. Despite that, inadequate responses always tended to be more frequent in the two groups of for every category of tests. Individually, the Valsalva index, which evaluates both branches of the autonomic system, was found to be the most sensitive parameter for detecting autonomic dysfunction in. Its frequency of abnormality was higher in receiving compared to either controls or. However, when dealing with autonomic tests, the starting point is that the diagnosis of autonomic dysfunction should not be based on the results of a single test. Using a battery of tests may be more reliable and informative [16]. When the frequencies of abnormal results in each category of tests for the three studied groups were analyzed, our findings suggested that ESRD alone was a significant determinant of impaired responses but only for the sympathetic branch of the autonomous nervous system. Sympathetic hyperactivity is known to be present in [17] and experimental animals [18] starting early in the course of chronic renal failure [19]. It is thought to be mediated by signals arising in the failing kidney [20]. However, these observations do not conflict with the present finding of predominant impairment of sympathetic responses in : first, 201
5 Autonomic Dysfunction in ESRD Hemodialysis International, Vol. 7, No. 3, 2003 because defective regulation of autonomic function is thought to involve mainly the afferent loop [21,22] and, second, because baseline hyperactivity may indeed contribute to impair adaptation to acute hemodynamic challenges such as those employed during autonomic testing. In other words, despite the tonic increased sympathetic activity, have reduced phasic sympathetic modulation. ESRD in combination with was a significant determinant of inadequate responses in every category of tests. Consistent with our findings, the initial hypothesis of an early and predominant involvement of the parasympathetic system [23 25] has recently been challenged [24,26]. The small number of patients in the present study makes inferences as to the effects of particular classes of antihypertensive drugs on the autonomic response difficult to make. However, the majority of antihypertensive drugs, if not all, are associated with perturbations of autonomic function. Some of them, such as beta blockers and a2-agonists, for example, have a mechanism of action intrinsically linked to impairment of sympathetic response [11,27]. In addition, drugs that diminish the production or the action of angiotensin II, which is known to activate catecholamine release in synapses, are associated with a reduction of sympathetic hyperactivity [28]. Except for one patient who was only taking nifedipine, all the others were receiving at least one of drugs known to be associated with attenuation of sympathetic activity or response. It is our view that the presence of such drugs may have unmasked otherwise undetectable defective parasympathetic responses. This may not be a unique situation considering that a similar finding was reported following clonidine administration to patients with essential hypertension [29]. To better assess the prevalence of autonomic dysfunction in we resorted to an analysis in which the frequency of one, more than one, more than two, and more than three positive tests were calculated for the three studied groups. Consistent with other findings, these results were more discriminative when the criterion of more than one positive test was used for the diagnosis [16]. From this perspective, abnormal numbers reached 64% for patients, 67% for those receiving such drugs, and 20% for controls. This last number is still somewhat high for a healthy control group, considering that a previous study employing a similar battery of autonomic tests has suggested a specificity of 94% [16]. The limited sample size could account for this, in part. In spite of the results in controls, the prevalence of autonomic dysfunction in in the present study remains quite impressive, being three times higher in both groups of in comparison to controls. In addition, the prevalence of inadequate autonomic responses in the present study are consistent with previous reports in which numbers vary from 50% to 100% [4,13,26]. In summary, autonomic dysfunction remains highly prevalent in undergoing current standard hemodialysis treatment. receiving BP drugs were found to have detectable impairment in the entire autonomic system in contrast to those in whom inadequate responses were restricted to the sympathetic branch. Whether represent an additional risk to autonomic dysfunction in ESRD patients or simply facilitate the detection of an underlying parasympathetic defect remains to be determined. References 1 Goldenberg S, Thompson A, Guha A, Kramer N, Parrish A. Autonomic nervous dysfunction in chronic renal failure. Clin Res. 1971; 19: Hennessy WJ, Siemsen AW. Autonomic neuropathy in chronic renal failure. Clin Res. 1968; 16: Malik S, Winney RJ, Ewing DJ. Chronic renal failure and cardiovascular autonomic function. Nephron. 1986; 43: Ewing DJ, Winney R. Autonomic function in patients with chronic renal failure on intermittent dialysis. Nephron. 1975; 15: Calvo C, Maule S, Mecca F, Quadri R, Martina G, Cavallo Perin P. The influence of autonomic neuropathy on hypotension during hemodialysis. Clin Auton Res. 2002; 12: Jassal SV, Coulshed SJ, Douglas JF, Stout RW. Autonomic neuropathy predisposing to arrhythmias in hemodialysis patients. Am J Kidney Dis. 1997; 30: Hathaway DK, Cashion AK, Milstead EJ, Winsett RP, Cowan PA, Wicks MN, Gaber AO. Autonomic dysregulation in patients awaiting transplantation. Am J Kidney Dis. 1998; 32: IV. NKF-K/DOQI clinical practice guidelines for anemia of chronic kidney disease. Am J Kidney Dis (1 suppl 1):S182 S Parker TF 3rd. Technical advances in hemodialysis therapy. Semin Dial. 2000; 13: Hingorani S, Watkins SL. Dialysis for end-stage renal disease. Curr Opin Pediatr. 2000; 12: Araújo CGS, Nóbrega ACL, Castro CLB. Heart rate response to deep breathing and 4-seconds of exercise before and after pharmacological blockade with atropine and propranolol. Clin Auton Res. 1992; 2: Lazarus JM, Denker BM, Owen WF Jr. Hemodialysis. In: Brenner BM, Rector FC, eds. The Kidney, 5th ed. Philadelphia: Saunders, 1995; Henrich WL. Hemodynamic instability during hemodialysis. Kidney Int. 1986; 30: La Rovere M, Specchia G, Montana A, Schwartz P. Baroreceptor sensitivity, clinical correlates and cardiovascular mortality amongst patients with a first myocardial infarction: a prospective study. Circulation. 1988; 78:
6 Hemodialysis International, Vol. 7, No. 3, Krivoshiev S, Vazelov E, Koteva A, Zlatarska S, Antonov S, Kirjakov Z. Does uraemic autonomic neuropathy increase the risk of sudden cardiac death? Nephrol Dial Transplant. 1989; 4: Vita G, Princi P, Savica V, Bellinghieri G, Puglisi RM, Marabello L, Messina C. Uremic autonomic dysfunction evaluated by pattern recognition analysis. Clin Nephrol. 1991; 6: Augustyniak RA, Tuncel M, Zhang W, Toto RD, Victor RG. Sympathetic overactivity as a cause of hypertension in chronic renal failure. J Hypertens. 2002; 20: Ye S, Zhong H, Yanamadala V, Campese VM. Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity. Am J Hypertens. 2002; 15: Tinucci T, Abrahao SB, Santello JL, Mion D Jr. Mild chronic renal insufficiency induces sympathetic overactivity. J Hum Hypertens. 2001; 15: Hausberg M, Kosch M, Harmelink P, Barenbrock M, Hohage H, Kisters K, Dietl KH, Rahn KH. Sympathetic nerve activity in end-stage renal disease. Circulation. 2002; 106: Rostand SG, Brunzell JD, Cannon RO 3rd, Victor RG. Cardiovascular complications in renal failure. J Am Soc Nephrol. 1991; 2: Vita G, Messina C, Savica V, Bellinghieri G. Uraemic autonomic neuropathy. J Auton Nerv Syst. 1990; 30(suppl):S179 S184. Lugon et al. 23 Chu TS, Tsai TJ, Lee SH, Yen TS. Evaluation of cardiovascular autonomic function tests in dialysis patients. J Formos Med Assoc. 1993; 92: Vita G, Bellinghieri G, Trusso A, Constantino G, Santoro D, Monteleone F, Messina C, Savica V. Uremic neuropathy studied by spectral analysis of heart rate. Kidney Int. 1999; 56: Campese VM. Orthostatic hypotension: idiopathic and uremic. Kidney Int. 1988; 34(suppl 25): S152 S Esforzado Armengol N, Amenos AC, Bono Illa M, Gaya Bertran J, Calls Ginesta J, Rivera Fillat F. Autonomic nervous system and adrenergic receptors in chronic hypotensive heamodialysis patients. Nephrol Dial Transplant. 1997; 12: Coupland NJ, Bailey JE, Wilson SJ, Horvath R, Nutt D. The effects of clonidine on cardiovascular responses to standing in healthy volunteers. Clin Auton Res. 1995; 5: Ma X, Chapleau MW, Whiteis CA, Abboud FM, Bielefeldt K. Angiotensin selectively activates a subpopulation of postganglionic sympathetic neurons in mice. Circ Res. 2001; 88: Lazzeri C, La Villa G, Mannelli M, Janni L, Barletta G, Montano N, Franchi F. Effects of clonidine on power spectral analysis of heart rate variability in mild essential hypertension. J Auton Nerv Syst. 1998; 74:
HRV in Diabetes and Other Disorders
HRV in Diabetes and Other Disorders Roy Freeman, MD Center for Autonomic and Peripheral Nerve Disorders Beth Israel Deaconess Medical Center Harvard Medical School Control Propranolol Atropine Wheeler
More informationNote: At the end of the instructions, you will find a table which must be filled in to complete the exercise.
Autonomic Nervous System Theoretical foundations and instructions for conducting practical exercises carried out during the course List of practical exercises 1. Deep (controlled) breath test 2. Cold pressor
More informationAvailable Online through
ISSN: 0975-766X CODEN: IJPTFI Available Online through Research Article www.ijptonline.com A STUDY OF AUTONOMIC NEUROPATHY IN PATIENTSOF CHRONIC RENAL FAILURE Venugopala. D *1, Sahil. K, Shyamala. K.V
More informationAutonomic Variation of Blood Pressure in Middle Aged Diabetics: A Prospective Study
Original Article DOI: 10.17354/ijss/2016/16 Autonomic Variation of Blood Pressure in Middle Aged Diabetics: A Prospective Study M Usharani 1, K Chandini 2 1 Professor and Head, Department of Physiology,
More informationMaher Fouad Ramzy; MD, FACP Professor of Renal Medicine, Cairo University
Hypertension in Hemodialysis Patient Maher Fouad Ramzy; MD, FACP Professor of Renal Medicine, Cairo University Mechanism of HTN in HD patients Volume-dependent HTN ECV expansion. Volume-independent HTN
More informationPOSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS) IT S NOT THAT SIMPLE
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS) IT S NOT THAT SIMPLE POTS Irritable heart syndrome. Soldier s heart. Effort syndrome. Vasoregulatory asthenia. Neurocirculatory asthenia. Anxiety neurosis.
More informationLab Period: Name: Physiology Chapter 14 Blood Flow and Blood Pressure, Plus Fun Review Study Guide
Lab Period: Name: Physiology Chapter 14 Blood Flow and Blood Pressure, Plus Fun Review Study Guide Main Idea: The function of the circulatory system is to maintain adequate blood flow to all tissues. Clinical
More informationBIPN100 F15 Human Physiol I (Kristan) Lecture 14 Cardiovascular control mechanisms p. 1
BIPN100 F15 Human Physiol I (Kristan) Lecture 14 Cardiovascular control mechanisms p. 1 Terms you should understand: hemorrhage, intrinsic and extrinsic mechanisms, anoxia, myocardial contractility, residual
More informationChallenges to Manage Blood Pressure in ESRD and Heart Failure Patients
Challenges to Manage Blood Pressure in ESRD and Heart Failure Patients Shweta Bansal, MD, FASN Associate Professor of Medicine UT Health San Antonio 2nd Annual Cardiorenal Connections Meeting, April 28,
More informationThe Exercise Pressor Reflex
The Exercise Pressor Reflex Dr. James P. Fisher School of Sport, Exercise & Rehabilitation Sciences College of Life & Environmental Sciences University of Birmingham, UK Copenhagen, 2018 Based on work
More informationStandardization of a computerized method for calculating autonomic function test responses in healthy subjects and patients with diabetes mellitus
Brazilian Standardization Journal of cardiovascular Medical and Biological autonomic Research function (1997) tests 3:197-25 ISSN 1-879X 197 Standardization of a computerized method for calculating autonomic
More informationHeart Failure Update John Coyle, M.D.
Heart Failure Update 2011 John Coyle, M.D. Causes of Heart Failure Anderson,B.Am Heart J 1993;126:632-40 It It is now well-established that at least one-half of the patients presenting with symptoms and
More informationInternational Journal of Basic and Applied Physiology
A STUDY OF CARDIOVASCULAR RESPONSES TO AUTONOMIC NERVE FUNCTIONS IN RHEUMATOID ARTHRITIS Ankur *, Rampure M Dilip **, Irshad Hussain Askari *** * Associate professor, Department of Physiology, MNR Medical
More informationSympathetic Vasomotor Response Of The Radial Artery In Patients With End Stage Renal Disease
ISPUB.COM The Internet Journal of Nephrology Volume 2 Number 1 Sympathetic Vasomotor Response Of The Radial Artery In Patients With End Stage Renal Disease L Galea, M Schembri, M Debono Citation L Galea,
More informationReducing proteinuria
Date written: May 2005 Final submission: October 2005 Author: Adrian Gillin Reducing proteinuria GUIDELINES a. The beneficial effect of treatment regimens that include angiotensinconverting enzyme inhibitors
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Blood Pressure Control role of specific antihypertensives
Blood Pressure Control role of specific antihypertensives Date written: May 2005 Final submission: October 2005 Author: Adrian Gillian GUIDELINES a. Regimens that include angiotensin-converting enzyme
More informationSYMPATHETIC STRESSORS AND SYMPATHETIC FAILURES
SYMPATHETIC STRESSORS AND SYMPATHETIC FAILURES Any discussion of sympathetic involvement in circulation, and vasodilation, and vasoconstriction requires an understanding that there is no such thing as
More informationCardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center
Cardiovascular Disease in CKD Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center Objectives Describe prevalence for cardiovascular disease in CKD
More informationPatients with chronic renal failure, and particularly patients
Sympathetic Nerve Activity in End-Stage Renal Disease Martin Hausberg, MD; Markus Kosch, MD; Patrick Harmelink, MS; Michael Barenbrock, MD; Helge Hohage, MD; Klaus Kisters, MD; Karl Heinz Dietl, MD; Karl
More informationHypertension. Penny Mosley MRPharmS
Hypertension Penny Mosley MRPharmS Outline of presentation Introduction to hypertension Physiological control of arterial blood pressure What determines our bp? What determines the heart rate? What determines
More informationAUTONOMIC FUNCTIONS IN BUERGER'S DISEASE
: 470-474 AUTONOMIC FUNCTIONS IN BUERGER'S DISEASE K. SINGH* AND S. SOOD Department of Physiology, Pt. B. D. Sharma, Postgraduate, Institute of Medical Sciences (PGIMS), Rohtak - 124 001 ( Received on
More informationInternational Journal of Research and Review E-ISSN: ; P-ISSN:
International Journal of Research and Review www.ijrrjournal.com E-ISSN: 2349-9788; P-ISSN: 2454-2237 Short Communication Rate Pressure Product in Diabetic Cardiac Autonomic Neuropathy at Rest and Under
More informationMedical Management of Acute Heart Failure
Critical Care Medicine and Trauma Medical Management of Acute Heart Failure Mary O. Gray, MD, FAHA Associate Professor of Medicine University of California, San Francisco Staff Cardiologist and Training
More informationClinico-demographic profile of type 2 diabetes patients with cardiac autonomic neuropathy
Original Research Article Clinico-demographic profile of type 2 diabetes patients with cardiac autonomic neuropathy Kothai G 1, Prasanna Karthik S 2* 1 Assistant Professor, Department of General Medicine,
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL 1 Supplemental Table 1. ICD codes Diagnoses, surgical procedures, and pharmacotherapy used for defining the study population, comorbidity, and outcomes Study population Atrial fibrillation
More informationCrisis Management During Liver Transplant Surgery Liver and Intensive Care Group of Europe Newcastle upon Tyne 2005
Crisis Management During Liver Transplant Surgery Liver and Intensive Care Group of Europe Newcastle upon Tyne 2005 M. Susan Mandell M.D. Ph. D. Department of Anesthesiology University of Colorado Health
More informationCardiac Output MCQ. Professor of Cardiovascular Physiology. Cairo University 2007
Cardiac Output MCQ Abdel Moniem Ibrahim Ahmed, MD Professor of Cardiovascular Physiology Cairo University 2007 90- Guided by Ohm's law when : a- Cardiac output = 5.6 L/min. b- Systolic and diastolic BP
More informationBaroreflex sensitivity and the blood pressure response to -blockade
Journal of Human Hypertension (1999) 13, 185 190 1999 Stockton Press. All rights reserved 0950-9240/99 $12.00 http://www.stockton-press.co.uk/jhh ORIGINAL ARTICLE Baroreflex sensitivity and the blood pressure
More informationStructure and organization of blood vessels
The cardiovascular system Structure of the heart The cardiac cycle Structure and organization of blood vessels What is the cardiovascular system? The heart is a double pump heart arteries arterioles veins
More informationCirculation. Blood Pressure and Antihypertensive Medications. Venous Return. Arterial flow. Regulation of Cardiac Output.
Circulation Blood Pressure and Antihypertensive Medications Two systems Pulmonary (low pressure) Systemic (high pressure) Aorta 120 mmhg Large arteries 110 mmhg Arterioles 40 mmhg Arteriolar capillaries
More informationProperties of Pressure
OBJECTIVES Overview Relationship between pressure and flow Understand the differences between series and parallel circuits Cardiac output and its distribution Cardiac function Control of blood pressure
More informationManagement of Hypertensive Chronic Kidney Disease: Role of Calcium Channel Blockers. Robert D. Toto, MD
R e v i e w P a p e r Management of Hypertensive Chronic Kidney Disease: Role of Calcium Channel Blockers Robert D. Toto, MD Both the prevalence and incidence of end-stage renal disease have been increasing
More informationDisorders of the Autonomic Nervous System: Part 2. Investigation and Treatment*
NEUROLOGICAL PROGRESS Disorders of the Autonomic Nervous System: Part 2. Investigation and Treatment* J. G. McLeod, PPhil, FRACP, and R. R. Tuck, PhD, FRACP Autonomic function may be adequately tested
More informationCardiac Drugs: Chapter 9 Worksheet Cardiac Agents. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate.
Complete the following. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate. 2. drugs affect the force of contraction and can be either positive or negative. 3.
More informationHYPERTENSION: Sustained elevation of arterial blood pressure above normal o Systolic 140 mm Hg and/or o Diastolic 90 mm Hg
Lecture 39 Anti-Hypertensives B-Rod BLOOD PRESSURE: Systolic / Diastolic NORMAL: 120/80 Systolic = measure of pressure as heart is beating Diastolic = measure of pressure while heart is at rest between
More informationCARDIAC OUTPUT,VENOUS RETURN AND THEIR REGULATION. DR.HAROON RASHID. OBJECTIVES
CARDIAC OUTPUT,VENOUS RETURN AND THEIR REGULATION. DR.HAROON RASHID. OBJECTIVES Define Stroke volume, Cardiac output Venous return,& identity their normal values. Describe control (intrinsic & extrinsic)
More informationCardiac arrhythmias. Janusz Witowski. Department of Pathophysiology Poznan University of Medical Sciences. J. Witowski
Cardiac arrhythmias Janusz Witowski Department of Pathophysiology Poznan University of Medical Sciences A 68-year old man presents to the emergency department late one evening complaining of increasing
More information8) BLOOD PRESSURE AND PULSE RATE RESPONSES TO SUSTAINED HANDGRIP DYNAMOMETER TEST IN RHEUMATOID ARTHRITIS PATENTS
8) BLOOD PRESSURE AND PULSE RATE RESPONSES TO SUSTAINED HANDGRIP DYNAMOMETER TEST IN RHEUMATOID ARTHRITIS PATENTS Dr. RANGRAO M. BHISE*, Dr. A.D.HATEKAR**, Dr. (Mrs.) S.D.KAUNDINYA*** *Corresponding author:
More informationChapter 9. Learning Objectives. Learning Objectives 9/11/2012. Cardiac Arrhythmias. Define electrical therapy
Chapter 9 Cardiac Arrhythmias Learning Objectives Define electrical therapy Explain why electrical therapy is preferred initial therapy over drug administration for cardiac arrest and some arrhythmias
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. ACE Inhibitor and Angiotensin II Antagonist Combination Treatment GUIDELINES
ACE Inhibitor and Angiotensin II Antagonist Combination Treatment Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES No recommendations possible based on Level
More informationVeins. VENOUS RETURN = PRELOAD = End Diastolic Volume= Blood returning to heart per cardiac cycle (EDV) or per minute (Venous Return)
Veins Venous system transports blood back to heart (VENOUS RETURN) Capillaries drain into venules Venules converge to form small veins that exit organs Smaller veins merge to form larger vessels Veins
More informationIntradialytic hypertension is a marker of volume excess
Nephrol Dial Transplant (2010) 1 of 6 doi: 10.1093/ndt/gfq210 NDT Advance Access published April 16, 2010 Original Article Intradialytic hypertension is a marker of volume excess Rajiv Agarwal 1,2 and
More informationPredicting and changing the future for people with CKD
Predicting and changing the future for people with CKD I. David Weiner, M.D. Co-holder, C. Craig and Audrae Tisher Chair in Nephrology Professor of Medicine and Physiology and Functional Genomics University
More informationCourse: Exercise and Aging for Special Populations
Copyright EFS Inc. All Rights Reserved. Course: Exercise and Aging for Special Populations Session 2: Cardiovascular and Metabolic Disease Considerations for Exercise Program Design Presentation Created
More informationUremic autonomic neuropathy studied by spectral analysis of heart rate
Kidney International, Vol. 56 (1999), pp. 232 237 CLINICAL NEPHROLOGY EPIDEMIOLOGY CLINICAL TRIALS Uremic autonomic neuropathy studied by spectral analysis of heart rate GIUSEPPE VITA, GUIDO BELLINGHIERI,
More informationImplanting a baroreceptor stimulation device for resistant hypertension
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Interventional procedure consultation document Implanting a baroreceptor stimulation device for resistant hypertension Hypertension (or high blood pressure)
More informationEvidence of Baroreflex Activation Therapy s Mechanism of Action
Evidence of Baroreflex Activation Therapy s Mechanism of Action Edoardo Gronda, MD, FESC Heart Failure Research Center IRCCS MultiMedica Cardiovascular Department Sesto S. Giovanni (Milano) Italy Agenda
More information(renoprotective (end-stage renal disease, ESRD) therapies) (JAMA)
[1], 1., 2. 3. (renoprotective (end-stage renal disease, ESRD) therapies) (JAMA) (multiple risk (renal replacement therapy, RRT) factors intervention treatment MRFIT) [2] ( 1) % (ESRD) ( ) ( 1) 2001 (120
More informationTodd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM
Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM Faculty Disclosure I have no financial interest to disclose No off-label use of medications will be discussed FIFTH ANNUAL SYMPOSIUM Recognize changes between
More informationHeart Failure (HF) Treatment
Heart Failure (HF) Treatment Heart Failure (HF) Complex, progressive disorder. The heart is unable to pump sufficient blood to meet the needs of the body. Its cardinal symptoms are dyspnea, fatigue, and
More informationHeart Failure. Subjective SOB (shortness of breath) Peripheral edema. Orthopnea (2-3 pillows) PND (paroxysmal nocturnal dyspnea)
Pharmacology I. Definitions A. Heart Failure (HF) Heart Failure Ezra Levy, Pharm.D. HF Results when one or both ventricles are unable to pump sufficient blood to meet the body s needs There are 2 types
More informationHypertension and diabetic nephropathy
Hypertension and diabetic nephropathy Elisabeth R. Mathiesen Professor, Chief Physician, Dr sci Dep. Of Endocrinology Rigshospitalet, University of Copenhagen Denmark Hypertension Brain Eye Heart Kidney
More informationThe ECG in healthy people
The ECG in healthy people The normal cardiac rhythm 3 The heart rate 3 Extrasystoles 7 The P wave 7 The PR interval The QRS complex 3 The ST segment 29 The T wave 33 The QT interval 42 The ECG in athletes
More informationClinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8. Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital
Clinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8 Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital Objectives Review the Eighth Joint National Committee (JNC
More information- Dr Alia Shatnawi. 1 P a g e
- 1 مها أبو عجمية - - - Dr Alia Shatnawi 1 P a g e A Skippable Intr0 Blood pressure normally decreases during the night. Absence of this phenomenon is called (nondipping) Wikipedia: Circadian rhythm....
More informationManagement of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine
Management of Hypertension M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine Disturbing Trends in Hypertension HTN awareness, treatment and control rates are decreasing
More informationStudy of relationship between QTC prolongation and cardiac autonomic neuropathy in Diabetes mellitus
Original Article Study of relationship between QTC prolongation and cardiac autonomic neuropathy in Diabetes mellitus N Natarajan, M S Ramaiyah, Associate Professor, Department of General Medicine, Kerala
More informationHypertension Update Warwick Jaffe Interventional Cardiologist Ascot Hospital
Hypertension Update 2008 Warwick Jaffe Interventional Cardiologist Ascot Hospital Definition of Hypertension Continuous variable At some point the risk becomes high enough to justify treatment Treatment
More informationA Study to Determine if T Wave Alternans is a Marker of Therapeutic Efficacy in the Long QT Syndrome
A Study to Determine if T Wave Alternans is a Marker of Therapeutic Efficacy in the Long QT Syndrome A. Tolat A. Statement of study rationale and purpose T wave alternans (TWA), an alteration of the amplitude
More information4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?
HYPERTENSION TARGETS: WHAT DO WE DO NOW? MICHAEL LEFEVRE, MD, MSPH PROFESSOR AND VICE CHAIR DEPARTMENT OF FAMILY AND COMMUNITY MEDICINE UNIVERSITY OF MISSOURI 4/4/17 DISCLOSURE: MEMBER OF THE JNC 8 PANEL
More informationβ adrenergic blockade, a renal perspective Prof S O McLigeyo
β adrenergic blockade, a renal perspective Prof S O McLigeyo Carvedilol Third generation β blocker (both β 1 and β 2 ) Possesses α 1 adrenergic blocking properties. β: α blocking ratio 7:1 to 3:1 Antioxidant
More information7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension
Prevalence of Hypertension Hypertension: Diagnosis and Management T. Villela, M.D. Program Director University of California, San Francisco-San Francisco General Hospital Family and Community Medicine
More informationTherefore MAP=CO x TPR = HR x SV x TPR
Regulation of MAP Flow = pressure gradient resistance CO = MAP TPR Therefore MAP=CO x TPR = HR x SV x TPR TPR is the total peripheral resistance: this is the combined resistance of all blood vessels (remember
More informationPHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD 5 mg/ ml THERAPEUTIC CLASSIFICATION Alpha-adrenoreceptor Blocker
PACKAGE INSERT Pr PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD 5 mg/ ml THERAPEUTIC CLASSIFICATION Alpha-adrenoreceptor Blocker ACTIONS AND CLINICAL PHARMACOLOGY Phentolamine produces an alpha-adrenergic
More informationMedical Treatment for acute Decompensated Heart Failure. Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011
Medical Treatment for acute Decompensated Heart Failure Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011 2010 HFSA guidelines for ADHF 2009 focused update of the 2005 American College
More informationALLHAT RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR)
1 RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) 6 / 5 / 1006-1 2 Introduction Hypertension is the second most common cause of end-stage
More informationRecommended Evaluation Data Excerpt from NVIC 04-08
Recommended Evaluation Data Excerpt from NVIC 04-08 Purpose: This document is an excerpt from the Medical and Physical Evaluations Guidelines for Merchant Mariner Credentials, contained in enclosure 3
More informationChapter 14 Blood Vessels, Blood Flow and Pressure Exam Study Questions
Chapter 14 Blood Vessels, Blood Flow and Pressure Exam Study Questions 14.1 Physical Law Governing Blood Flow and Blood Pressure 1. How do you calculate flow rate? 2. What is the driving force of blood
More informationIs estimation of laser Doppler skin perfusion pressure appropriate during hemodialysis enforcement?
ISPUB.COM The Internet Journal of Cardiovascular Research Volume 6 Number 2 Is estimation of laser Doppler skin perfusion pressure appropriate during hemodialysis enforcement? M Shimazaki Citation M Shimazaki.
More informationOnline Appendix (JACC )
Beta blockers in Heart Failure Collaborative Group Online Appendix (JACC013117-0413) Heart rate, heart rhythm and prognostic effect of beta-blockers in heart failure: individual-patient data meta-analysis
More informationIraqi JMS. Effect of Dialysate Temperature on Hemodynamic Stability among Hemodialysis Patients. Tarik A. Hussein 1 FICMS, Arif S.
Iraqi JMS Published by Al-Nahrain College of Medicine ISSN 1681-6579 Email: iraqijms@colmed-alnahrain.edu.iq http://www.colmed-nahrain.edu.iq Effect of Dialysate Temperature on Hemodynamic Stability among
More informationIndications and Uses of Testing. Laboratory Testing of Autonomic Function. Generalized Autonomic Failure. Benign Disorders 12/30/2012.
Indications and Uses of Testing Laboratory Testing of Autonomic Function Conditions of generalized autonomic failure Help define the degree of autonomic dysfunction and distinguish more benign from life
More informationHypertension (JNC-8)
Hypertension (JNC-8) Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 17, 2018, presented by Ezra Levy, Pharm.D.! The 8 th Joint
More informationStress echo workshop STRESSORS
Stress echo workshop STRESSORS Adham Ahmed, MD Lecturer of Cardiology, Ain Shams Indications of Stress Echo CAD Diagnosis Prognosticat ion 1 Physiologic Basis 1930s: Tennant and Wiggers Relationship between
More informationDr Doris M. W Kinuthia
Dr Doris M. W Kinuthia Objectives Normal blood pressures in children Measurement of blood pressure in children Aetiology of Hypertension in children Evaluation of children with hypertension Treatment of
More informationDuring exercise the heart rate is 190 bpm and the stroke volume is 115 ml/beat. What is the cardiac output?
The Cardiovascular System Part III: Heart Outline of class lecture After studying part I of this chapter you should be able to: 1. Be able to calculate cardiac output (CO) be able to define heart rate
More informationDRUG CLASSES BETA-ADRENOCEPTOR ANTAGONISTS (BETA-BLOCKERS)
DRUG CLASSES BETA-ADRENOCEPTOR ANTAGONISTS (BETA-BLOCKERS) Beta-blockers have been widely used in the management of angina, certain tachyarrhythmias and heart failure, as well as in hypertension. Examples
More informationAtrial fibrillation in the ICU
Atrial fibrillation in the ICU Atrial fibrillation Preexisting or incident (new onset) among nearly one in three critically ill patients Formation of arrhythogenic substrate usually fibrosis (CHF, hypertension,
More informationHypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B)
Practice Guidelines and Principles: Guidelines and principles are intended to be flexible. They serve as reference points or recommendations, not rigid criteria. Guidelines and principles should be followed
More informationManagement of new-onset AF: Initial rate control treatment
Geneva Acute Crdiovascular Care Congress 2014 - October 18-20, 2014 Management of new-onset AF: Initial rate control treatment Antonio Raviele, MD, FESC, FHRS ALFA Alliance to Fight Atrial fibrillation,
More information4. The two inferior chambers of the heart are known as the atria. the superior and inferior vena cava, which empty into the left atrium.
Answer each statement true or false. If the statement is false, change the underlined word to make it true. 1. The heart is located approximately between the second and fifth ribs and posterior to the
More informationIntegrated Cardiopulmonary Pharmacology Third Edition
Integrated Cardiopulmonary Pharmacology Third Edition Chapter 3 Pharmacology of the Autonomic Nervous System Multimedia Directory Slide 19 Slide 37 Slide 38 Slide 39 Slide 40 Slide 41 Slide 42 Slide 43
More informationEffects of Kidney Disease on Cardiovascular Morbidity and Mortality
Effects of Kidney Disease on Cardiovascular Morbidity and Mortality Joachim H. Ix, MD, MAS Assistant Professor in Residence Division of Nephrology University of California San Diego, and Veterans Affairs
More informationALLHAT. Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic
1 U.S. Department of Health and Human Services National Institutes of Health Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker
More informationCedars Sinai Diabetes. Michael A. Weber
Cedars Sinai Diabetes Michael A. Weber Speaker Disclosures I disclose that I am a Consultant for: Ablative Solutions, Boston Scientific, Boehringer Ingelheim, Eli Lilly, Forest, Medtronics, Novartis, ReCor
More informationijcrr Vol 04 issue 10 Category: Research Received on:20/04/12 Revised on:25/04/12 Accepted on:01/05/12
INFLUENCE OF ALTERNATE NOSTRIL BREATHING ON CARDIORESPIRATORY FUNCTIONS AMONG HYPERTENSIVE SUBJECTS ijcrr Vol 04 issue 10 Category: Research Received on:20/04/12 Revised on:25/04/12 Accepted on:01/05/12
More informationHypertension. Most important public health problem in developed countries
Hypertension Strategy for Continued Success in Treatment for the 21st Century November 15, 2005 Arnold B. Meshkov, M.D. Associate Professor of Medicine Temple University School of Medicine Philadelphia,
More informationBlood Pressure. a change in any of these could cause a corresponding change in blood pressure
Blood Pressure measured as mmhg Main factors affecting blood pressure: 1. cardiac output 2. peripheral resistance 3. blood volume a change in any of these could cause a corresponding change in blood pressure
More informationHypotension During Haemodialysis: Aetiology, Risk Factors and Outcome
ORIGINAL ARTICLE Hypotension During Haemodialysis: Aetiology, Risk Factors and Outcome *N Mahmood 1, MMU Hassan 2, F Mahmood 3, S Bari4 Background: Hypotension during hemodialysis is common. In some patients,
More informationIntravenous Iron Requirement in Adult Hemodialysis Patients
Intravenous Iron Requirement in Adult Hemodialysis Patients Timothy V. Nguyen, PharmD The author is a clinical pharmacy specialist with Holy Name Hospital in Teaneck, New Jersey. He is also an adjunct
More informationCardiorenal Syndrome: What the Clinician Needs to Know. William T. Abraham, MD Director, Division of Cardiovascular Medicine
Cardiorenal Syndrome: What the Clinician Needs to Know William T. Abraham, MD Director, Division of Cardiovascular Medicine Orlando, Florida October 7-9, 2011 Renal Hemodynamics in Heart Failure Glomerular
More information1. Antihypertensive agents 2. Vasodilators & treatment of angina 3. Drugs used in heart failure 4. Drugs used in arrhythmias
1. Antihypertensive agents 2. Vasodilators & treatment of angina 3. Drugs used in heart failure 4. Drugs used in arrhythmias Only need to know drugs discussed in class At the end of this section you should
More informationProf. Andrzej Wiecek Department of Nephrology, Endocrinology and Metabolic Diseases Medical University of Silesia Katowice, Poland.
What could be the role of renal denervation in chronic kidney disease? Andrzej Wiecek, Katowice, Poland Chairs: Peter J. Blankestijn, Utrecht, The Netherlands Jonathan Moss, Glasgow, UK Prof. Andrzej Wiecek
More informationBlood pressure. Formation of the blood pressure: Blood pressure. Formation of the blood pressure 5/1/12
Blood pressure Blood pressure Dr Badri Paudel www.badripaudel.com Ø Blood pressure means the force exerted by the blood against the vessel wall Ø ( or the force exerted by the blood against any unit area
More informationHypertension and Heart Disease. Weldon James, MD, Mercy Clinic Family Medicine, Union
Hypertension and Heart Disease Weldon James, MD, Mercy Clinic Family Medicine, Union The Silent Killer High blood pressure, also known as HBP or hypertension, is a widely misunderstood medical condition
More informationRESISTENT HYPERTENSION. Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University
RESISTENT HYPERTENSION Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University Resistant Hypertension Blood pressure remaining above goal in spite of concurrent use of 3 antihypertensive
More informationMorning Hypertension: A Pitfall of Current Hypertensive Management
Review Article Hypertension: A Pitfall of Current Hypertensive Management JMAJ 48(5): 234 240, 2005 Kazuomi Kario* 1 Abstract has recently attracted more attention because of the close relation between
More informationPITTMed Cardiology. Pharmacology Modules. Learning Objectives. Site Contents. Fall 2018
PITTMed Cardiology Fall 2018 Site Contents Pharmacology Modules Please complete the following modules during the first week of class: Adrenergics Cholinergics Adrenergic Drugs in Cardiology Hypercalcemia
More informationHypertension: What s new since JNC 7. Harold M. Szerlip, MD, FACP, FCCP, FASN, FNKF
Hypertension: What s new since JNC 7 Harold M. Szerlip, MD, FACP, FCCP, FASN, FNKF Disclosures Spectral Diagnostics Site investigator Eli Lilly Site investigator ACP IM ITE writing committee NBME Step
More information